Han, J. W., & Yoon, Y. S. (2011). Induced pluripotent stem cells: emerging techniques for nuclear reprogramming. Antioxid Redox Signal, 15(7), 1799-1820.

Hodara, R., Weiss, D., Joseph, G., Velasquez-Castano, J. C., Landazuri, N., Han, J. W., Yoon, Y. S., & Taylor, W. R. (2011). Overexpression of catalase in myeloid cells causes impaired postischemic neovascularization. Arterioscler Thromb Vasc Biol, 31(10), 2203-2209.

Park, C., Lee, J. Y., & Yoon, Y. S. (2011). Role of bone marrow-derived lymphatic endothelial progenitor cells for lymphatic neovascularization. Trends Cardiovasc Med, 21(5), 135-140.

Szulwach, K. E., Li, X., Li, Y., Song, C. X., Han, J. W., Kim, S., Namburi, S., Hermetz, K., Kim, J. J., Rudd, M. K., Yoon, Y. S., Ren, B., He, C., & Jin, P. (2011). Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells. PLoS Genet, 7(6), e1002154.

Jeong, J. O., Han, J. W., Kim, J. M., Cho, H. J., Park, C., Lee, N., Kim, D. W., & Yoon, Y. S. (2011). Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circ Res, 108(11), 1340-1347.

Kim, S. W., Kim, H., & Yoon, Y. S. (2011). Advances in bone marrow-derived cell therapy: CD31-expressing cells as next generation cardiovascular cell therapy. Regen Med, 6(3), 335-349.

Andukuri, A., Kushwaha, M., Tambralli, A., Anderson, J. M., Dean, D. R., Berry, J. L., Sohn, Y. D., Yoon, Y.-S., Brott, B. C., & Jun, H.-W. (2011). A hybrid biomimetic nanomatrix composed of electrospun polycaprolactone and bioactive peptide amphiphiles for cardiovascular implants. Acta Biomaterialia, 7(1), 225-233.

Kishore, R., Tkebuchava, T., Sasi, S. P., Silver, M., Gilbert, H. Y., Yoon, Y. S., Park, H. Y., Thorne, T., Losordo, D. W., & Goukassian, D. A. (2011). Tumor necrosis factor-alpha signaling via TNFR1/p55 is deleterious whereas TNFR2/p75 signaling is protective in adult infarct myocardium. Adv Exp Med Biol, 691, 433-448.